FOXA1 and metabolic dysfunction-associated steatotic liver disease: Consistently, our study indicated that liver-specific FoxA1 knockout contributed to the development of NAFLD in mice, and restoration of FoxA1 expression effectively suppressed lipid droplet formation via enhancing fatty acid β-oxidation.